Rigosertib sodium

CAS: 592542-60-4

Ref. 3D-BR175409

Produktinformation

• Name: Rigosertib sodium
• Marke: Biosynth
• Beschreibung: Rigosertib sodium is an experimental chemotherapeutic agent that is a derivative of benzyl styryl sulfone. It is synthesized chemically and functions primarily by inhibiting key signaling pathways involved in cancer cell proliferation. Specifically, Rigosertib targets the RAS signaling pathway along with the phosphatidylinositol-3-kinase/AKT and polo-like kinase 1 (Plk1) pathways, impeding the progression of the cell cycle and inducing apoptosis in malignant cells.

Chemische Eigenschaften

• Molekulargewicht: 473.47 g/mol
• Formel: C₂₁H₂₄NNaO₈S
• Reinheit: Min. 95%
• Farbe/Form: White Powder